Previous Close | 1.64 |
1-Year Change | 14.69% |
6-Months Change | 24.24% |
3-Months Change | 5.81% |
Moving Avg (50d) | 1.515 |
Moving Avg (200d) | 1.3295 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.23B |
Beta (3-Years) | 1.43 |
Revenue Growth (ttm) | -28.95% |
Net Profit Margin (ttm) | -23.95% |
Return On Assets (ttm) | -10.09% |
EPS (ttm) | -0.27 |
PE Ratio (ttm) | -6.07 |
Dividend Yield | % |
Asset Description: | OPKO Health, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-11 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
1.548 | 1.501 | 1.469 | 1.422 | 1.343 | 1.264 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Life Sciences Tools & Services |
Country: | United States |